Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 148082, 8 pages
http://dx.doi.org/10.1155/2015/148082
Review Article

Advances in the Pathogenesis of Cardiorenal Syndrome Type 3

1Department of Nephrology and Dialysis, San Giovanni Di Dio, Agrigento 92100, Italy
2Department of Nephrology, Dialysis and Transplant, San Bortolo Hospital, Vicenza 36100, Italy
3International Renal Research Institute Vicenza (IRRIV), Italy
4Clinical Genetics Unit, Department of Women’s and Children’s Health, University of Padua, Italy
5Department of Medicine (DIMED), University of Padova, Padova 35128, Italy
6Internal Medicine, San Bortolo Hospital, Vicenza 36100, Italy

Received 18 November 2014; Accepted 23 February 2015

Academic Editor: Ersin Fadillioglu

Copyright © 2015 Anna Clementi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. R. Molls and H. Rabb, “Limiting deleterious cross-talk between failing organs,” Critical Care Medicine, vol. 32, no. 11, pp. 2358–2359, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Ronco, M. Haapio, A. A. House, N. Anavekar, and R. Bellomo, “Cardiorenal Syndrome,” Journal of the American College of Cardiology, vol. 52, no. 19, pp. 1527–1539, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Y. Goh, G. Vizzi, M. de Cal, and C. Ronco, “Cardiorenal syndrome: a complex series of combined heart/kidney disorders,” Contributions to Nephrology, vol. 174, pp. 33–45, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. P. A. McCullough, J. A. Kellum, M. Haase et al., “Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the acute dialysis quality initiative (adqi),” Contributions to Nephrology, vol. 182, pp. 82–98, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. S. M. Bagshaw, D. N. Cruz, N. Aspromonte et al., “Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference,” Nephrology Dialysis Transplantation, vol. 25, no. 5, pp. 1406–1416, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. S. C. Yap and H. T. Lee, “Acute kidney injury and extrarenal organ dysfunction: new concepts and experimental evidence,” Anesthesiology, vol. 116, no. 5, pp. 1139–1148, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. E. M. Levy, C. M. Viscoli, and R. I. Horwitz, “The effect of acute renal failure on mortality: a cohort analysis,” The Journal of the American Medical Association, vol. 275, no. 19, pp. 1489–1494, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. L. E. White and H. T. Hassoun, “Inflammatory mechanisms of organ crosstalk during ischemic acute kidney injury,” International Journal of Nephrology, vol. 2012, Article ID 505197, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Chuasuwan and J. A. Kellum, “Epidemiology, pathophysiology, and treatment,” Seminars in Nephrology, vol. 32, no. 1, pp. 31–39, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. L. G. Bongartz, M. J. Cramer, P. A. Doevendans, J. A. Joles, and B. Braam, “The severe cardiorenal syndrome: ‘guyton revisited’,” European Heart Journal, vol. 26, no. 1, pp. 11–17, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Shalhoub, M. A. Falck-Hansen, A. H. Davies, and C. Monaco, “Innate immunity and monocyte-macrophage activation in atherosclerosis,” Journal of Inflammation, vol. 8, article 9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. T. H. Mogensen, “Pathogen recognition and inflammatory signaling in innate immune defenses,” Clinical Microbiology Reviews, vol. 22, no. 2, pp. 240–273, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. G. R. Kinsey, L. Li, and M. D. Okusa, “Inflammation in acute kidney injury,” Nephron—Experimental Nephrology, vol. 109, no. 4, pp. e102–e107, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. G. M. Virzì, S. Day, M. de Cal, G. Vescovo, and C. Ronco, “Heart-kidney crosstalk and role of humoral signaling in critical illness,” Critical Care, vol. 18, no. 1, article 201, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. D. L. Rosin and M. D. Okusa, “Dangers within: DAMP responses to damage and cell death in kidney disease,” Journal of the American Society of Nephrology, vol. 22, no. 3, pp. 416–425, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. H. R. Jang and H. Rabb, “The innate immune response in ischemic acute kidney injury,” Clinical Immunology, vol. 130, no. 1, pp. 41–50, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Li and M. D. Okusa, “Macrophages, dendritic cells, and kidney ischemia-reperfusion injury,” Seminars in Nephrology, vol. 30, no. 3, pp. 268–277, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. T. J. Soos, T. N. Sims, L. Barisoni et al., “CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney,” Kidney International, vol. 70, no. 3, pp. 591–596, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Li, L. Huang, S. S. J. Sung et al., “The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury,” Kidney International, vol. 74, no. 12, pp. 1526–1537, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Dong, S. Swaminathan, L. A. Bachman, A. J. Croatt, K. A. Nath, and M. D. Griffin, “Resident dendritic cells are the predominant tnf-secreting cell in early renal ischemia-reperfusion injury,” Kidney International, vol. 71, no. 7, pp. 619–628, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Li, L. Huang, A. L. Vergis et al., “IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury,” The Journal of Clinical Investigation, vol. 120, no. 1, pp. 331–342, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Li and M. D. Okusa, “Blocking the immune response in ischemic acute kidney injury: the role of adenosine 2a agonists,” Nature Clinical Practice Nephrology, vol. 2, no. 8, pp. 432–444, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. Y.-J. Day, L. Huang, H. Ye, L. Li, J. Linden, and M. D. Okusa, “Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-γ,” Journal of Immunology, vol. 176, no. 5, pp. 3108–3114, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. D. B. Ascon, S. Lopez-Briones, M. Liu et al., “Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury,” Journal of Immunology, vol. 177, no. 5, pp. 3380–3387, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Hochegger, T. Schätz, P. Eller et al., “Role of alpha/beta and gamma/delta t cells in renal ischemia-reperfusion injury,” The American Journal of Physiology—Renal Physiology, vol. 293, no. 3, pp. F741–F747, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Kalogeris, C. P. Baines, M. Krenz, and R. J. Korthuis, “Cell biology of ischemia/reperfusion injury,” International Review of Cell and Molecular Biology, vol. 298, pp. 229–317, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Akcay, Q. Nguyen, and C. L. Edelstein, “Mediators of inflammation in acute kidney injury,” Mediators of Inflammation, vol. 2009, Article ID 137072, 12 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. K. J. Kelly, “Distant effects of experimental renal ischemia/reperfusion injury,” Journal of the American Society of Nephrology, vol. 14, no. 6, pp. 1549–1558, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Li, L. Huang, S.-S. J. Sung et al., “NKT cell activation mediates neutrophil IFN-γ production and renal eschemia-reperfusion injury,” Journal of Immunology, vol. 178, no. 9, pp. 5899–5911, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. K. J. Kelly, W. W. Williams Jr., R. B. Colvin et al., “Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury,” The Journal of Clinical Investigation, vol. 97, no. 4, pp. 1056–1063, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Wu, G. Chen, K. R. Wyburn et al., “Tlr4 activation mediates kidney ischemia/reperfusion injury,” The Journal of Clinical Investigation, vol. 117, no. 10, pp. 2847–2859, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. M. M. Givertz and W. S. Colucci, “New targets for heart-failure therapy: endothelin, inflammatory cytokines, and oxidative stress,” The Lancet, vol. 352, supplement 1, pp. S34–S38, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. S. R. Kapadia, “Cytokines and heart failure,” Cardiology in Review, vol. 7, no. 4, pp. 196–206, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Ernst, D. E. Hammerschmidt, U. Bagge, A. Matrai, and J. A. Dormandy, “Leukocytes and the risk of ischemic diseases,” The Journal of the American Medical Association, vol. 257, no. 17, pp. 2318–2324, 1987. View at Publisher · View at Google Scholar · View at Scopus
  35. J. E. Núñez, E. Núñez, V. Bertomeu et al., “Prognostic value of baseline white blood cell count in patients with acute myocardial infarction and st segment elevation,” Heart, vol. 91, no. 8, pp. 1094–1095, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Dragu, S. Khoury, R. Zuckerman et al., “Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction,” Atherosclerosis, vol. 196, no. 1, pp. 405–412, 2008. View at Publisher · View at Google Scholar
  37. M. H. Bae, J. H. Lee, D. H. Yang, H. S. Park, Y. Cho, and S. C. Chae, “White blood cell, hemoglobin and platelet distribution width as short-term prognostic markers in patients with acute myocardial infarction,” Journal of Korean Medical Science, vol. 29, no. 4, pp. 519–526, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Burchill, E. Velkoska, R. G. Dean et al., “Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression,” Experimental Physiology, vol. 93, no. 5, pp. 622–630, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Bozkurt, S. B. Kribbs, F. J. Clubb Jr. et al., “Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats,” Circulation, vol. 97, no. 14, pp. 1382–1391, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Mantovani, R. Bonecchi, and M. Locati, “Tuning inflammation and immunity by chemokine sequestration: decoys and more,” Nature Reviews Immunology, vol. 6, no. 12, pp. 907–918, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Fox, A. E. Leitch, R. Duffin, C. Haslett, and A. G. Rossi, “Neutrophil apoptosis: relevance to the innate immune response and inflammatory disease,” Journal of Innate Immunity, vol. 2, no. 3, pp. 216–227, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Michlewska, I. Dransfield, I. L. Megson, and A. G. Rossi, “Macrophage phagocytosis of apoptotic neutrophils is critically regulated by the opposing actions of pro-inflammatory and anti-inflammatory agents: key role for tnf-alpha,” The FASEB Journal, vol. 23, no. 3, pp. 844–854, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Ortega-Gómez, M. Perretti, and O. Soehnlein, “Resolution of inflammation: an integrated view,” The EMBO Molecular Medicine, vol. 5, no. 5, pp. 661–674, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. S. D. Prabhu, “Cytokine-induced modulation of cardiac function,” Circulation Research, vol. 95, no. 12, pp. 1140–1153, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. R. A. Zager, A. C. M. Johnson, and S. Lund, “Uremia impacts renal inflammatory cytokine gene expression in the setting of experimental acute kidney injury,” The American Journal of Physiology—Renal Physiology, vol. 297, no. 4, pp. F961–F970, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. M. J. Tracz, J. P. Juncos, A. J. Croatt et al., “Deficiency of heme oxygenase-1 impairs renal hemodynamics and exaggerates systemic inflammatory responses to renal ischemia,” Kidney International, vol. 72, no. 9, pp. 1073–1080, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Hirota, K. Yoshida, T. Kishimoto, and T. Taga, “Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 11, pp. 4862–4866, 1995. View at Publisher · View at Google Scholar · View at Scopus
  48. P. Blake, Y. Hasegawa, M. C. Khosla, F. Fouad-Tarazi, N. Sakura, and E. P. Paganini, “Isolation of ‘myocardial depressant factor(s)’ from the ultrafiltrate of heart failure patients with acute renal failure,” ASAIO Journal, vol. 42, no. 5, pp. M911–M915, 1996. View at Publisher · View at Google Scholar · View at Scopus
  49. C. G. Kuhar, M. V. Budihna, and R. Z. Pleskovič, “Mibefradil is more effective than verapamil for restoring post-ischemic function of isolated hearts of guinea pigs with acute renal failure,” European Journal of Pharmacology, vol. 488, no. 1–3, pp. 137–146, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Przyklenk, B. Bauer, M. Ovize, R. A. Kloner, and P. Whittaker, “Regional ischemic ‘preconditioning’ protects remote virgin myocardium from subsequent sustained coronary occlusion,” Circulation, vol. 87, no. 3, pp. 893–899, 1993. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Kanoria, R. Jalan, A. M. Seifalian, R. Williams, and B. R. Davidson, “Protocols and mechanisms for remote ischemic preconditioning: a novel method for reducing ischemia reperfusion injury,” Transplantation, vol. 84, no. 4, pp. 445–458, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. E. Ateş, E. Gency̧, N. Erkasap et al., “Renal protection by brief liver ischemia in rats,” Transplantation, vol. 74, no. 9, pp. 1247–1251, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Takaoka, I. Nakae, K. Mitsunami et al., “Renal ischemia/reperfusion remotely improves myocardial energy metabolism during myocardial ischemia via adenosine receptors in rabbits: effects of 'remote preconditioning',” Journal of the American College of Cardiology, vol. 33, no. 2, pp. 556–564, 1999. View at Publisher · View at Google Scholar · View at Scopus
  54. B. C. G. Gho, R. G. Schoemaker, M. A. van den Doel, D. J. Duncker, and P. D. Verdouw, “Myocardial protection by brief ischemia in noncardiac tissue,” Circulation, vol. 94, no. 9, pp. 2193–2200, 1996. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Tsutamoto, T. Hisanaga, D. Fukai et al., “Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure,” The American Journal of Cardiology, vol. 76, no. 11, pp. 803–808, 1995. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Faubel, “Acute kidney injury and multiple organ dysfunction syndrome,” Minerva Urologica e Nefrologica, vol. 61, no. 3, pp. 171–188, 2009. View at Google Scholar · View at Scopus
  57. J. J. Cohen, R. C. Duke, V. A. Fadok, and K. S. Sellins, “Apoptosis and programmed cell death in immunity,” Annual Review of Immunology, vol. 10, pp. 267–293, 1992. View at Publisher · View at Google Scholar · View at Scopus
  58. K. J. Kelly, S. M. Meehan, R. B. Colvin, W. W. Williams Jr., and J. V. Bonventre, “Protection from toxicant-mediated renal injury in the rat with anti-CD54 antibody,” Kidney International, vol. 56, no. 3, pp. 922–931, 1999. View at Publisher · View at Google Scholar · View at Scopus
  59. S. M. Bagshaw, E. A. Hoste, B. Braam et al., “Cardiorenal syndrome type 3: pathophysiologic and epidemiologic considerations,” Contributions to Nephrology, vol. 182, pp. 137–157, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Cannavo, D. Liccardo, and W. J. Koch, “Targeting cardiac beta-adrenergic signaling via grk2 inhibition for heart failure therapy,” Frontiers in Physiology, vol. 4, article 264, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. W. S. Colucci, “The effects of norepinephrine on myocardial biology: implications for the therapy of heart failure,” Clinical Cardiology, vol. 21, no. 12, pp. I20–I24, 1998. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Luchner and H. Schunkert, “Interactions between the sympathetic nervous system and the cardiac natriuretic peptide system,” Cardiovascular Research, vol. 63, no. 3, pp. 443–449, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. Z. Zukowska-Grojec, “Neuropeptide Y—a novel sympathetic stress hormone and more,” Annals of the New York Academy of Sciences, vol. 771, pp. 219–233, 1995. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Kim and H. Iwao, “Molecular and cellular mechanisms of angiotensin ii-mediated cardiovascular and renal diseases,” Pharmacological Reviews, vol. 52, no. 1, pp. 11–34, 2000. View at Google Scholar · View at Scopus
  65. J. Kajstura, E. Cigola, A. Malhotra et al., “Angiotensin II induces apoptosis of adult ventricular myocytes in vitro,” Journal of Molecular and Cellular Cardiology, vol. 29, no. 3, pp. 859–870, 1997. View at Publisher · View at Google Scholar · View at Scopus
  66. H. Kawano, Y. S. Do, Y. Kawano et al., “Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts,” Circulation, vol. 101, no. 10, pp. 1130–1137, 2000. View at Publisher · View at Google Scholar · View at Scopus
  67. B. N. Shah and K. Greaves, “The cardiorenal syndrome: a review,” International Journal of Nephrology, vol. 2011, Article ID 920195, 11 pages, 2011. View at Publisher · View at Google Scholar
  68. F. Qin, R. Patel, C. Yan, and W. Liu, “Nadph oxidase is involved in angiotensin ii-induced apoptosis in h9c2 cardiac muscle cells: effects of apocynin,” Free Radical Biology and Medicine, vol. 40, no. 2, pp. 236–246, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. T. Chabrashvili, C. Kitiyakara, J. Blau et al., “Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 285, no. 1, pp. R117–R124, 2003. View at Google Scholar · View at Scopus
  70. H. Nakagami, M. Takemoto, and J. K. Liao, “NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy,” Journal of Molecular and Cellular Cardiology, vol. 35, no. 7, pp. 851–859, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. K. K. Griendling, C. A. Minieri, J. D. Ollerenshaw, and R. W. Alexander, “Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells,” Circulation Research, vol. 74, no. 6, pp. 1141–1148, 1994. View at Publisher · View at Google Scholar · View at Scopus
  72. K. Bomsztyk and O. Denisenko, “Epigenetic alterations in acute kidney injury,” Seminars in Nephrology, vol. 33, no. 4, pp. 327–340, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. W. A. Burgers, F. Fuks, and T. Kouzarides, “DNA methyltransferases get connected to chromatin,” Trends in Genetics, vol. 18, no. 6, pp. 275–277, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. C. Napoli, A. Casamassimi, V. Crudele, T. Infante, and C. Abbondanza, “Kidney and heart interactions during cardiorenal syndrome: a molecular and clinical pathogenic framework,” Future Cardiology, vol. 7, no. 4, pp. 485–497, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. A. Portela and M. Esteller, “Epigenetic modifications and human disease,” Nature Biotechnology, vol. 28, no. 10, pp. 1057–1068, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Eulalio, M. Mano, M. D. Ferro et al., “Functional screening identifies miRNAs inducing cardiac regeneration,” Nature, vol. 492, no. 7429, pp. 376–381, 2012. View at Publisher · View at Google Scholar · View at Scopus
  77. R. Nistala, M. R. Hayden, V. G. DeMarco, E. J. Henriksen, D. T. Lackland, and J. R. Sowers, “Prenatal programming and epigenetics in the genesis of the cardiorenal syndrome,” Cardiorenal Medicine, vol. 1, no. 4, pp. 243–254, 2011. View at Publisher · View at Google Scholar
  78. T. Rimmelé and J. A. Kellum, “Oliguria and fluid overload,” Contributions to Nephrology, vol. 164, pp. 39–45, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. J. Bouchard and R. L. Mehta, “Fluid balance issues in the critically III patient,” Contributions to Nephrology, vol. 164, pp. 69–78, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. M. E. Grams, M. M. Estrella, J. Coresh, R. G. Brower, and K. D. Liu, “Fluid balance, diuretic use, and mortality in acute kidney injury,” Clinical Journal of the American Society of Nephrology, vol. 6, no. 5, pp. 966–973, 2011. View at Publisher · View at Google Scholar · View at Scopus
  81. R. Bellomo, A. Cass, L. Cole et al., “An observational study fluid balance and patient outcomes in the randomized evaluation of normal vs. Augmented level of replacement therapy trial,” Critical Care Medicine, vol. 40, pp. 1753–1760, 2012. View at Google Scholar
  82. R. Bellomo, A. Cass, L. Cole et al., “Intensity of continuous renal-replacement therapy in critically ill patients,” The New England Journal of Medicine, vol. 361, no. 17, pp. 1627–1638, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. P. M. Palevsky, J. H. Zhang, T. Z. O'Connor et al., “Intensity of renal support in critically ill patients with acute kidney injury,” The New England Journal of Medicine, vol. 359, no. 1, pp. 7–20, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. V. Schwenger, M. A. Weigand, O. Hoffmann et al., “Sustained low efficiency dialysis using a single-pass batch system in acute kidney injury—a randomized interventional trial: the renal replacement therapy study in intensive care unit patients,” Critical Care, vol. 16, article R140, 2012. View at Google Scholar
  85. J. F. Zazzo, G. Troche, P. Ruel, and J. Maintenant, “High incidence of hypophosphatemia in surgical intensive care patients: efficacy of phosphorus therapy on myocardial function,” Intensive Care Medicine, vol. 21, no. 10, pp. 826–831, 1995. View at Publisher · View at Google Scholar · View at Scopus
  86. S. Demirjian, B. W. Teo, J. A. Guzman et al., “Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury,” Nephrology Dialysis Transplantation, vol. 26, no. 11, pp. 3508–3514, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. T. Bombardini, M. Zoppè, Q. Ciampi et al., “Myocardial contractility in the stress echo lab: from pathophysiological toy to clinical tool,” Cardiovascular Ultrasound, vol. 11, no. 1, article 41, 2013. View at Publisher · View at Google Scholar · View at Scopus
  88. M. Luo and M. E. Anderson, “Mechanisms of altered Ca2+ handling in heart failure,” Circulation Research, vol. 113, no. 6, pp. 690–708, 2013. View at Publisher · View at Google Scholar · View at Scopus
  89. A. J. Nimmo, N. Than, C. H. Orchard, and E. M. Whitaker, “The effect of acidosis on beta-adrenergic receptors in ferret cardiac muscle,” Experimental Physiology, vol. 78, no. 1, pp. 95–103, 1993. View at Publisher · View at Google Scholar · View at Scopus
  90. C. G. Musso, “Magnesium metabolism in health and disease,” International Urology and Nephrology, vol. 41, no. 2, pp. 357–362, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. F. Duranton, G. Cohen, R. de Smet et al., “Normal and pathologic concentrations of uremic toxins,” Journal of the American Society of Nephrology, vol. 23, no. 7, pp. 1258–1270, 2012. View at Publisher · View at Google Scholar · View at Scopus
  92. A. Torremans, B. Marescau, R. Vanholder, R. de Smet, J.-M. Billiouw, and P. P. de Deyn, “The low nanomolar levels of NG-monomethylarginine in serum and urine of patients with chronic renal insufficiency are not significantly different from control levels,” Amino Acids, vol. 24, no. 4, pp. 375–381, 2003. View at Publisher · View at Google Scholar · View at Scopus